Skip to main content
Cellromax Science Co., Ltd. logo

Cellromax Science Co., Ltd. — Investor Relations & Filings

Ticker · 471820 ISIN · KR7471820001 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2024-12-20 Director's Dealing
Country KR South Korea
Listing KO 471820

About Cellromax Science Co., Ltd.

https://www.cellromax.kr/

Cellromax Science Co., Ltd. is a company specializing in the research, development, and manufacturing of health-related products. Its portfolio is centered on three key areas: health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company leverages scientific research and high-quality, naturally derived ingredients to create unique and effective products. Its development philosophy emphasizes optimized formulas and specialized prescriptions designed to support consumer health, skin vitality, and overall well-being.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is a standard regulatory requirement for insiders (directors, officers, and major shareholders) to disclose their shareholdings and changes in ownership. In the provided taxonomy, this falls under 'Director's Dealing' (DIRS), which covers reports of share transactions and ownership status by company insiders.
2024-12-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory disclosure for insider transactions or changes in share ownership by company directors/executives. In the provided classification schema, 'Director's Dealing' (DIRS) is the correct category for reports detailing personal share transactions by company directors and executives.
2024-12-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). This type of filing is specifically used to disclose insider shareholdings and transactions by directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2024-12-20 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition and subsequent sale of shares by 'Ubiquoss Investment' in 'Cellromax Science'. This type of filing is used to notify the market of significant changes in share ownership (crossing thresholds). In the provided classification schema, 'Major Shareholding Notification' (MRQ) is the correct category for filings that report changes in significant share ownership levels.
2024-12-17 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date for the shareholder register in preparation for an upcoming Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory announcement of the record date. Given the nature of the announcement and its brevity, it falls under the general regulatory filing category.
2024-12-16 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory announcement regarding the setting of a record date for shareholder register closure for the purpose of future dividend distribution. It explicitly states that it is not a dividend declaration itself, but rather a procedural step to determine shareholders eligible for future dividends. Given the nature of the announcement as a regulatory notice regarding corporate actions, it fits best under the RNS (Regulatory Filings) category as it does not meet the criteria for a specific dividend payment announcement (DIV) or other categories.
2024-12-16 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.